Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2000
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/06/2000EP1057827A1 Spiropiperidine derivatives
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
12/06/2000EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056728A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000CN1275564A Quinoline ketone derivant and antianaphylaction using same as active substance
12/06/2000CN1059125C Traditional Chinese medicine for treating chronic bronchitis
12/06/2000CN1059107C Medicinal composition for treating chronic obstructive disease of lung and its preparing process
12/06/2000CN1059090C Syrup for treating cough and asthma and productive method thereof
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156781 Antiinflammatory agents for skin
12/05/2000US6156756 Anticoagulants
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156734 Cardiovascular disorders
12/05/2000US6156523 Serine/threonine protein kinases
11/2000
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071424A1 Method and apparatus for distributing powder
11/30/2000WO2000071419A1 Method and apparatus for loading a container with a product
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071118A1 Phospholipase a2-specific inhibiting compounds
11/30/2000WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]
11/30/2000WO2000071108A2 Methods for treatment of asthma using s-oxybutynin
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000042993A3 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041694A3 Compositions having improved stability
11/30/2000WO2000041693A3 Compositions having improved delivery of actives
11/30/2000WO2000041692A3 Compositions having improved stability
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2375543A1 Salts of cis-¬4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate|
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374668A1 New pharmaceutical combinations for nos inhibitors
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2373783A1 Method and apparatus for loading a container with a product
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371923A1 Methods for treatment of asthma using s-oxybutynin
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054685A1 Liquid crystal forms of cyclosporin
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275128A Pyrazolo (3,4-D) pyrimidines with anticonvulsive and antialiergic/antiasthmatic action
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1275052A Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1274601A Immunity-strengthening and infection-preventing medicine
11/29/2000CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture
11/29/2000CN1058894C Compound cold-preventing nose drops and their preparation
11/29/2000CN1058891C Medicine for treating child asthma type bronchitis
11/29/2000CN1058883C Chinese medicine preparation for treatment of bronchial asthma
11/29/2000CN1058874C Medical composition against snore and preparation and application thereof
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants